- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 327/30 - Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
Patent holdings for IPC class C07C 327/30
Total number of patents in this class: 55
10-year publication summary
|
2
|
3
|
1
|
3
|
3
|
2
|
6
|
4
|
1
|
4
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7948 |
12 |
| Abliva AB | 39 |
7 |
| Translate bio, Inc. | 416 |
5 |
| University of Sunderland | 14 |
3 |
| Hoffmann-La Roche Inc. | 3478 |
2 |
| Nagoya Industrial Science Research Institute | 21 |
2 |
| Nippon Zoki Pharmaceutical Co., Ltd. | 143 |
2 |
| The Royal Veterinary College | 46 |
2 |
| Techfields Pharma Co., Ltd. | 30 |
2 |
| Kabushiki Kaisha Toshiba, doing business as Toshiba Corporation | 6261 |
2 |
| Shenzhen Rhegen Biotechnology Co., Ltd. | 41 |
2 |
| The Regents of the University of California | 20108 |
1 |
| Wisconsin Alumni Research Foundation | 3884 |
1 |
| Advanced Biodesign | 20 |
1 |
| Chemelectiva S.r.l | 11 |
1 |
| Dongjin Semichem Co., Ltd. | 486 |
1 |
| Krisani Biosciences Pvt. Ltd. | 2 |
1 |
| Nabriva Therapeutics AG | 14 |
1 |
| Shinshu University | 474 |
1 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2874 |
1 |
| Other owners | 5 |